These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9600586)

  • 1. The effect of venlafaxine treatment on the behavioural and neurochemical changes in the olfactory bulbectomised rat.
    McGrath C; Norman TR
    Psychopharmacology (Berl); 1998 Apr; 136(4):394-401. PubMed ID: 9600586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (+)-S-20499 -- a potential antidepressant? A behavioural and neurochemical investigation in the olfactory bulbectomised rat.
    McGrath C; Norman TR
    Eur Neuropsychopharmacol; 1999 Jan; 9(1-2):21-7. PubMed ID: 10082224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Onset of the effects of the 5-HT1A antagonist, WAY-100635, alone, and in combination with paroxetine, on olfactory bulbectomy and 8-OH-DPAT-induced changes in the rat.
    Cryan JF; McGrath C; Leonard BE; Norman TR
    Pharmacol Biochem Behav; 1999 Jun; 63(2):333-8. PubMed ID: 10371664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic fluoxetine treatment attenuates stressor-induced changes in temperature, heart rate, and neuronal activation in the olfactory bulbectomized rat.
    Roche M; Harkin A; Kelly JP
    Neuropsychopharmacology; 2007 Jun; 32(6):1312-20. PubMed ID: 17119540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of venlafaxine on extracellular concentrations of 5-HT and noradrenaline in the rat frontal cortex: augmentation via 5-HT1A receptor antagonism.
    Dawson LA; Nguyen HQ; Geiger A
    Neuropharmacology; 1999 Aug; 38(8):1153-63. PubMed ID: 10462128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desipramine administration in the olfactory bulbectomized rat: changes in brain beta-adrenoceptor and 5-HT2A binding sites and their relationship to behaviour.
    Mudunkotuwa NT; Horton RW
    Br J Pharmacol; 1996 Apr; 117(7):1481-6. PubMed ID: 8730743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Open-field behavioural alterations in liver-impaired and sham-operated rats after acute exposure to the antidepressant venlafaxine.
    Kugelberg FC; Apelqvist G; Wikell C; Bengtsson F
    Basic Clin Pharmacol Toxicol; 2005 Sep; 97(3):155-61. PubMed ID: 16128909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Psychopharmacological profile of venlafaxine].
    Bourin M
    Encephale; 1999 Jun; 25 Spec No 2():21-2; discussion 23-5. PubMed ID: 10434156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-dependent noradrenergic and serotonergic properties of venlafaxine in animal models indicative of antidepressant activity.
    Redrobe JP; Bourin M; Colombel MC; Baker GB
    Psychopharmacology (Berl); 1998 Jul; 138(1):1-8. PubMed ID: 9694520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of addition of yohimbine (alpha-2-receptor antagonist) to the antidepressant activity of fluoxetine or venlafaxine in the mouse forced swim test.
    Dhir A; Kulkarni SK
    Pharmacology; 2007; 80(4):239-43. PubMed ID: 17622775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of serotonin 5-HT1A receptors in the antidepressant-like effect and the antinociceptive effect of venlafaxine in mice.
    Berrocoso E; Mico JA
    Int J Neuropsychopharmacol; 2009 Feb; 12(1):61-71. PubMed ID: 18405417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of venlafaxine in the sleep architecture of rats.
    Salin-Pascual RJ; Moro-Lopez ML
    Psychopharmacology (Berl); 1997 Feb; 129(3):295-6. PubMed ID: 9084070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidepressant-induced modulation of GABAA receptors and beta-adrenoceptors but not GABAB receptors in the frontal cortex of olfactory bulbectomised rats.
    Dennis T; Beauchemin V; Lavoie N
    Eur J Pharmacol; 1994 Sep; 262(1-2):143-8. PubMed ID: 7813565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of beta adrenoceptor desensitization in brain following the dual noradrenaline and serotonin reuptake inhibitor venlafaxine.
    Nalepa I; Manier DH; Gillespie DD; Rossby SP; Schmidt DE; Sulser F
    Eur Neuropsychopharmacol; 1998 Aug; 8(3):227-32. PubMed ID: 9716317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular adaptation to chronic antidepressant treatment: evidence for a more rapid response to the novel α₂-adrenoceptor antagonist/5-HT-noradrenaline reuptake inhibitor (SNRI), S35966, compared to the SNRI, venlafaxine.
    Serres F; Millan MJ; Sharp T
    Int J Neuropsychopharmacol; 2012 Jun; 15(5):617-29. PubMed ID: 21733241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity and onset of action of reboxetine and effect of combination with sertraline in an animal model of depression.
    Harkin A; Kelly JP; McNamara M; Connor TJ; Dredge K; Redmond A; Leonard BE
    Eur J Pharmacol; 1999 Jan; 364(2-3):123-32. PubMed ID: 9932714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: I. in vivo electrophysiological studies in the rat.
    Béïque J; de Montigny C; Blier P; Debonnel G
    Neuropharmacology; 2000 Jul; 39(10):1800-12. PubMed ID: 10884561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine.
    Millan MJ; Gobert A; Lejeune F; Newman-Tancredi A; Rivet JM; Auclair A; Peglion JL
    J Pharmacol Exp Ther; 2001 Aug; 298(2):565-80. PubMed ID: 11454918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidepressant-like activity of VN2222, a serotonin reuptake inhibitor with high affinity at 5-HT1A receptors.
    Tordera RM; Monge A; Del Río J; Lasheras B
    Eur J Pharmacol; 2002 May; 442(1-2):63-71. PubMed ID: 12020683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for an antihyperalgesic effect of venlafaxine in vincristine-induced neuropathy in rat.
    Marchand F; Alloui A; Pelissier T; Hernández A; Authier N; Alvarez P; Eschalier A; Ardid D
    Brain Res; 2003 Aug; 980(1):117-20. PubMed ID: 12865165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.